Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited) (Parenthetical)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Class of Stock [Line Items]
Warrants exercise price (in dollars per share)			$ 0.57
Stock Issuance January 2021 [Member]
Class of Stock [Line Items]
Price per share			$ 0.80
Transactional expenses			$ 3,096
Stock Issuance February 2021 [Member]
Class of Stock [Line Items]
Price per share			$ 1.20
Transactional expenses			$ 5,002
Stock Issuance At Market Offering January 2021 [Member]
Class of Stock [Line Items]
Transactional expenses			$ 230
Stock Issuance At Market Offering April And June 2021 [Member]
Class of Stock [Line Items]
Transactional expenses		$ 612
Stock Issuance At Market Offering July, August and September 2021 [Member]
Class of Stock [Line Items]
Transactional expenses	$ 389
Stock Issuance February And March 2020 [Member]
Class of Stock [Line Items]
Warrants exercise price (in dollars per share)						$ 0.57
Stock issuance February 2020 [Member]
Class of Stock [Line Items]
Price per share						$ 1,000.00
Transactional expenses						$ 711
Stock Issuance February 2020 [Member]
Class of Stock [Line Items]
Warrants exercise price (in dollars per share)						$ 0.57
Transactional expenses						$ 292
Stock Issuance March 2020 [Member]
Class of Stock [Line Items]
Warrants exercise price (in dollars per share)						$ 1.10
Transactional expenses						$ 1,221
Stock Issuance At Market Offering May And June 2020 [Member]
Class of Stock [Line Items]
Transactional expenses					$ 1,131
Stock Issuance July 2020 [Member]
Class of Stock [Line Items]
Transactional expenses				$ 829
Stock Issuance At Market Offering September 2020 [Member]
Class of Stock [Line Items]
Transactional expenses				$ 267